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Molecularly Imprinted Polymers (MIPs) against S-ibuprofen were synthesised using a tailor made
functional monomer, 2-acrylamido-4-methylpyridine, following extensive pre-polymerisation studies
of template–monomer complexation. An apparent association constant of 340 22M1 was calculated
that was subsequently corrected to account for dimerisation of ibuprofen (Kdim ¼ 320  95 M1)
resulting in an intrinsic association constant of 715  16 M1, consistent with previously reported
values. Using the synthesised imprinted polymer as a stationary phase, complete resolution of a racemic
mixture of ibuprofen was achieved in predominantly aqueous mobile phases. An imprinting factor of
10 was observed, and was found to be in agreement with the difference in the average number of
binding sites between MIP and blank polymers, calculated by staircase frontal chromatography. The
imprinted polymers exhibited enhanced selectivity for the templated drug over structurally related
NSAIDs. When applied as sorbents in solid-phase extraction of ibuprofen from commercial tablets,
urine and blood serum samples, recoveries up to 92.2% were achieved.
1. Introduction
Molecular imprinting is a technique that enables the generation
of specific binding sites within the matrix of a synthetic organic
polymer, analogous to the binding sites found in nature’s own
specific receptors, enzymes and antibodies.1–6 Commonly, the
generation of such imprinted sites within the polymer matrix is
achieved by utilising non-covalent interactions between the
template of interest and a complementary functional monomer at
the pre-polymerisation stage. Hence, upon initiation of the
polymerisation reaction, it is theorised that the template is held in
close proximity to the growing polymer chains and a cast is
generated around it that upon its extraction, reveals the binding
site that is then capable of reversibly binding the templated
analyte or closely related compounds. The strength of template–
monomer interactions is therefore critical for the fidelity of the
binding sites formed. Commercially available monomers such as
methacrylic acid (MAA) and vinyl-4-pyridine (4-VPy) have been
used extensively in MIP synthesis with varying degrees of
success. With few exceptions,7 interactions between these func-
tional monomers and templates are weak, single point hydrogen
bonds, and an excess of functional monomer is commonly
employed in order to drive the equilibrium towards complex
formation. This excess of functional monomer results in random
distribution of functionality within the polymer and conse-
quently non-specific binding of the analytes to the polymer
matrix at the application stage. Additionally, the limited strength
of template–monomer and subsequently template–imprinted
polymer interactions has limited their applications to predomi-
nantly organic media, as addition of an aqueous modifier
disrupts the weak hydrogen bonding and leads to excessive non-
specific binding.
These shortfalls have been overcome by designing functional
monomers capable of forming strong interactions with a partic-
ular template, thus eliminating the need for an excess of func-
tional monomer and therefore reducing the degree of non-
specific binding.8–11 Stoichiometric ratios of the functional
monomer and the template are used at the pre-polymerisation
stage, forming strong pre-polymerisation complexes, which
subsequently generate imprinted polymers with high affinity
binding sites.
Ibuprofen is a member of the non-steroidal anti-inflammatory
drugs (NSAIDs) and is commonly used for relief from arthritis,
fever and as a generic pain reliever. Being one of the most
popular drugs of its category, it has attracted significant research
interest over the past years, and a number of reports of its tar-
geting by molecular imprinting are found in literature. An early
study by Kempe and Mosbach investigated the enantio-selective
properties of S-naproxen imprinted polymers prepared using
4-VPy as the functional monomer.12 Enantio-separation of
a racemic mixture of naproxen was achieved using an organic
mobile phase, with a separation factor of 1.65. Caro et al.
prepared ibuprofen imprinted polymers using a similar monomer
composition and used it as an SPE sorbent for selective extrac-
tion of ibuprofen, naproxen, benzoic acid, fenoprofen and
diclofenac from spiked river water samples.13 The polymer was
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capable of selective extraction of the tested analytes and per-
formed similarly to a commercial SPE sorbent. However, chro-
matographic evaluation of the imprinted polymer revealed rather
low imprinting factors for ibuprofen and naproxen. In another
study, Haginaka et al. prepared S-ibuprofen imprinted beads,
generated by multi-step swelling and a thermal polymerisation
method.14 The imprinted beads were employed as a HPLC
chromatographic stationary phase using a mixture of organic–
aqueous mobile phases. An imprinting factor of 2.08 was
calculated for S-ibuprofen, while it was lower for structurally
related compounds. Furthermore, only partial enantio-separa-
tion of ibuprofen enantiomers was achieved. In a more recent
study Spegel et al. prepared imprinted polymers by in situ poly-
merisation for enantiomeric separation of ibuprofen using
capillary electrochromatography.15 Although a range of poly-
mers with varying compositions of the starting materials were
prepared using 4-VPy as the functional monomer, only partial
separation of enantiomers was achieved.
In contrast to previous reports detailed above, where
commercially available 4-VPy was used as the functional
monomer, the work presented here details the design and prep-
aration of S-ibuprofen-specific stoichiometric imprinted poly-
mers using a tailor-made functional monomer, 2-acrylamido-4-
methylpyridine.16 Initially, an in-depth investigation of pre-
polymerisation complexes was performed using NMR spectros-
copy, whereby it was possible to deconvolute the apparent
association constant from the dimerisation of ibuprofen itself,
reported here for the first time. The subsequently synthesised
imprinted polymer was employed as a chromatographic
stationary phase. Using a 30 mm HPLC column and a predom-
inantly aqueous mobile phase, the imprinted polymer was
capable of complete enantiomeric separation of racemic
ibuprofen in less than 30 minutes. Furthermore, selectivity of the
imprinted polymer was demonstrated by the superior specific
binding of S-ibuprofen compared to its structurally related
compounds (Scheme 1) with calculated imprinting factors of up
to 10. The imprinted polymer was also used as a selective SPE
sorbent for the extraction of ibuprofen from commercial tablets,
blood serum and urine samples with recoveries of up to 92.2%.
2. Experimental
2.1. Materials and methods
Ethyleneglycol dimethacrylate (EDMA), 1,10-azobis(cyclohex-
anecarbonitrile) (ACCN), 2-amino-4-picoline, triethylamine,
deuterated chloroform (CDCl3), HPLC grade solvents, acetoni-
trile, methanol, dichloromethane, toluene, and anhydrous
tetrahydrofuran were purchased from Sigma-Aldrich (Wicklow,
Ireland). Acryloyl chloride was purchased from VWR Interna-
tional (Dublin, Ireland). Water was purified by a SG Ultra Clear
TWF UV Plus TM water purification system (Whitewater,
Blackrock, Ireland). EDMA was purified by washing with 10%
NaOH, washing with brine, drying over anhydrous magnesium
sulfate, and subsequent distillation under reduced pressure. The
functional monomer, 2-acrylamido-4-methylpyridine (AMP),
was synthesised as reported previously by reacting equimolar
amounts of amino-4-picoline and acryloyl chloride in the pres-
ence of triethylamine.16,17
NMR spectra were obtained using a Jeol ECX 400 spec-
trometer (Tokyo, Japan). HPLC measurements were performed
using an Agilent 1200 system equipped with a diode array
detector. Surface area analysis was performed using a Micro-
meritics Gemini VI Nitrogen sorption analyser (Particular
Sciences, Dublin, Ireland).
2.2. Pre-polymerisation studies
Monomer–template, monomer–monomer and template–
template complexation were studied prior to polymer synthesis
to establish the type and strength of interactions present in the
pre-polymerisation solution, by means of a 1H NMR titration
and dilution studies in CDCl3. In the first instance, to a solution
of AMP (0.001 mol L1) were added increasing amounts of the
guest S-ibuprofen. The complexation-induced shift (CIS) of the
host amide proton was followed, and titration curves were then
constructed. The raw titration data was fitted to a 1 : 1 binding
isotherm, and the association constant was obtained by
nonlinear regression of the isotherms using WinEQNMR2 soft-
ware.18 Secondly, a standard solution of AMP or S-ibuprofen
(0.1 mol L1) was sequentially diluted to 0.001 mol L1 and the
self-association induced shift of the amide proton (AMP) or the
proton on the methylene adjacent to the carboxyl group
(S-ibuprofen) was followed. The stoichiometry of the AMP–S-
ibuprofen complex was confirmed using Job’s method of
continuous variation.19 Hence, equimolar solutions (0.01 mol
L1) of AMP and S-ibuprofen were mixed in different ratios and
plots of Dd against the molar fraction of AMP multiplied by the
CIS (XAMP  Dd) were constructed.
2.3. Preparation of imprinted polymers
A stoichiometric 1 : 1 ratio of functional monomer (AMP) and
template plus 20 equivalents of the cross-linker were employed in
the synthesis of the imprinted polymers. 0.206 g (1 mmol) of S-
ibuprofen and 0.163 g (1 mmol) of AMPwere dissolved in 5.6 mL
of toluene followed by addition of 4 g (20 mmol) of EDMA in
a 20 mL screw-cap vial. The solution was degassed using N2
while cooling in an ice-bath for 5 minutes. Finally, 0.04 g of the
free radical initiator ACCN were added and the vial was sealed
and placed in a UV reactor at 4 C for 24 hours. A non-imprinted
polymer (NIP) was synthesised in the same manner with omis-
sion of the template. The resulting monoliths were smashed to
coarse particles and washed with methanol for 24 hours using
a Soxhlet apparatus. Finally, the polymers were manually
Scheme 1 Proposed mode of interaction between the functional
monomer (AMP) and S-ibuprofen plus the chemical structures of related
NSAIDs.
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ground and sieved collecting the 25–38 mm fraction for packing
into HPLC columns and SPE cartridges.
2.4. Chromatographic evaluation
Imprinted or non-imprinted particles of 25–38 mm were slurry
packed in 30 mm  4.6 mm i.d. HPLC columns using a 4 : 1
methanol : water mixture. The columns were then connected to
a HPLC instrument and equilibrated with acetonitrile until
a stable baseline was obtained. Analyses were performed at
0.5 mLmin1 by injecting 5 mL of a 0.1 mmol L1 solution of each
analyte and recording its elution profile at 220 or 240 nm. All
injections were repeated at least three times, alternating between
the different analytes to avoid column overloading. Imprinting
factors (kMIP/kNIP) for each analyte as well as separation factors
(kS/kR) for the template were calculated.
Staircase frontal chromatography was performed using solu-
tions of S-ibuprofen in acetonitrile as the mobile phase, ranging
from 0.001 to 0.1 mol L1, and mixing them in a step-wise fashion
of 10% increments with pure acetonitrile to produce a staircase
frontal chromatogram with a total of 30 steps. From each step
the corresponding amount of bound analyte was calculated and
the collected results were plotted against the corresponding
concentration of S-ibuprofen to produce binding isotherms that
were fitted using the Freundlich binding model.20,21
2.5. Solid phase extractions
25 mg of MIP and NIP particles were dry packed in 3 mL SPE
cartridges using 20 mm porous PTFE frits. Equilibration of the
columns, loading and washing were performed using 2 mL
aliquots of the corresponding solutions and elution of the
retained analytes with 1 mL of CH3CN–1% CH3COOH. Full
vacuum was applied between each step for 3 minutes in order to
dry the stationary phases. The collected fractions were analysed
by HPLC using a 150 mm  4.6 mm 5 mm C18 column and
isocratic elution using a mixture of methanol : water : acetic acid
90 : 5 : 5 with the flow-rate set at 1 mL min1. Under these
conditions ibuprofen eluted at 1.9 minutes. Commercial
ibuprofen tablets were ground to a fine powder and dissolved in
ultrapure water prior to analysis. Blood serum samples were
prepared by allowing the collected blood to clot at room
temperature for approximately 45 minutes, followed by centri-
fugation at 3000 rpm for 15 minutes, and careful collection of the
clear top layer. Serum samples were stored at 80 C. SPE
analysis of serum samples was performed in spiked samples
(200 mg mL1) after dilution with ultra-pure water. Urine samples
were filtered, spiked and analysed following dilution with ultra-
pure water. The protocol for biological sample analysis was
approved by the Institutional Ethics Committee and written
consent was obtained.
3. Results and discussion
3.1. Pre-polymerisation studies
In a previous report on the use of acrylamido pyridines for the
recognition of carboxylic acids, Hall et al. performed an exten-
sive study on the influence of substitution of the pyridine ring on
binding strength.16 2-Acrylamido-4-methylpyridine was found to
be the strongest receptor and hence it was selected as the func-
tional monomer for the present study. A 1H NMR titration
revealed that its apparent association constant with S-ibuprofen
(Kapp) was 340  22 M1 in CDCl3 at 20 C (Fig. 1). This is
significantly lower that the constant calculated for the binding of
propanoic acid (777  84 M1), used as model in the previous
study. This observation cannot be explained by either the
difference in the pKa of S-ibuprofen (pKa ¼ 4.9) and propanoic
acid (pKa ¼ 4.7), or the larger molecular size and flexibility of
ibuprofen. A further set of NMR based experiments was there-
fore performed, this time investigating the dimerisation of both
AMP and ibuprofen, facilitated by the self-complementary H-
bond donor–acceptor motif present in both molecules. The first
dilution study revealed very weak, yet detectable, self-association
of AMP calculated at approximately 10  0.8 M1. This was
deemed too weak to have any significant bearing on the overall
equilibrium and was considered negligible. However, the dilution
study of ibuprofen (Fig. 1, insert) revealed a significant dimer-
isation equilibrium with Kdim¼ 320 95 M1, very similar to the
apparent association constant calculated for the AMP–ibuprofen
complex. When this second equilibrium was taken into account,
we were able to re-plot the original 1 : 1 binding isotherm and
using non-linear regression an intrinsic Ka ¼ 715  16 M1 was
calculated for the AMP–ibuprofen complex, in agreement with
the previously reported value. To our knowledge, this is the first
time that the dimerisation of ibuprofen has been studied,
certainly in the context of molecular imprinting, although the
dimerisation of carboxylic acids is a well-studied phenomenon.22
The stoichiometry of the AMP–ibuprofen complex was veri-
fied by a Job plot experiment. This showed a maximum at
XAMP ¼ 0.5, verifying the 1 : 1 stoichiometry as expected by the
two point interaction postulated in Scheme 1 and supporting our
use of a stoichiometric imprinting protocol.
3.2. Preparation and characterisation of imprinted polymers
Imprinted and non-imprinted polymers were synthesised using
a 1 : 1 : 20 ratio of S-ibuprofen : AMP : EDMA by
Fig. 1 1H NMR titration binding isotherm of S-ibuprofen with AMP:
experimental data (triangles), corresponding fitted curve (dashed line),
data corrected for self-association of ibuprofen (squares) and corre-
sponding fitted curve (solid line). Insert: S-ibuprofen self-association
isotherm obtained by 1H NMR dilution study and corresponding fitted
curve.
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photochemical initiation at 4 C using UV irradiation. Toluene
was chosen as the porogen, in order to facilitate and stabilise
template–monomer interactions due to its non-polar nature, but
also to yield polymers with relatively high surface area. The
similar mesoporous nature of the polymers was confirmed by N2
porosimetry with a surface area of 398 m2 g1 and an average
pore diameter of 71 A for the MIP and 431 m2 g1 with average
pore diameter of 69.5 A for the NIP. Both MIP and NIP
monoliths appeared semi-transparent and a slight colour differ-
ence was observed upon visual examination under visible and
UV light, possibly due to a complexation induced change in the
absorption characteristics of AMP.
Following Soxhlet extraction of the polymers, 13C solid state
NMR analysis of the materials was performed with nearly
identical spectra obtained, as seen in Fig. 2. Spin-lattice (T1)
relaxation times were also measured by inversion recovery
experiments and were found to be 0.6 seconds for the MIP and
0.55 seconds for the NIP, demonstrating the comparable physical
character of the two polymers.
3.3. Chromatographic evaluation of imprinted polymers
HPLC evaluation of the synthesised materials was initially per-
formed in pure acetonitrile. S-Ibuprofen was the longest retained
analyte with a corresponding imprinting factor (kMIP/kNIP) of
5. The R-enantiomer was significantly less retained and a
kMIP/kNIP ¼ 3.2 was measured. When racemic ibuprofen was
injected a split peak was observed corresponding to the R and S
enantiomers, with a separation factor a ¼ kS/kR of 1.5. This
finding suggested that complete enantio-separation could be
possible, if the elution conditions were further optimised.
The retention profiles of the other injected analytes also
revealed some interesting trends. The much smaller analyte 2-
phenylpropanoic acid, as well as larger indoprofen, were less
retained, similarly to the geometrically different naproxen and
ketoprofen (Table 1). It is however noteworthy that of all ana-
lytes tested, S-flurbiprofen and S-naproxen, both comparable in
size and shape to the templated S-ibuprofen, exhibited slightly
higher retention than the other analytes tested, highlighting
a size-exclusion effect taking place within the polymer’s binding
sites. Furthermore, the slightly more acidic character of these
analytes, as calculated using Marvin software package,23 might
also be responsible for their marginally longer retention. It
should be noted here that in all cases no enantio-separation was
observed when racemic mixtures were injected.
In order to optimise the mobile phase composition, the
percentage of water in acetonitrile was incremented in steps of
10%. When 60% water content was used, complete resolution of
ibuprofen enantiomers was achieved in approximately 30
minutes and an a ¼ 1.8 was calculated, while the imprinting
factor for S-ibuprofen was equal to 10, a 5-fold increase
compared to previously reported literature values.
Fig. 2 13C solid state NMR spectra (100 MHz) of imprinted (top) and non-imprinted polymers (bottom) with assignment of major peaks.
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The composition of each of the two peaks was verified by
injection of pure S-ibuprofen and it was verified that this was the
longer retained enantiomer, while the non-templated R-enan-
tiomer eluted first. At water contents higher than 70% chro-
matographic run times exceeded 60 minutes and the quality of
the peaks diminished significantly, hence 60% water content was
used for the further evaluation of the polymers. The obtained
imprinting factors are presented in Fig. 3.
As expected, the relative hydrophobic character of NSAIDs
resulted in significantly longer retention of all injected analytes,
compared to the analyses in pure organic medium, with S-flur-
biprofen and S-naproxen being retained the longest compared to
the other structurally related analytes. Moreover the imprinted
polymer exhibited enantio-selectivity for flurbiprofen as its
racemic mixture was nearly completely resolved (a ¼ 1.4). This
result was attributed to the comparable size and shape of this
analyte to the templated structure.
Further optimisation of the chromatographic conditions was
attempted by means of temperature control. Thus, a series of
injections of rac-ibuprofen was performed at 20, 40 and 60 C
and the elution profiles were recorded. It was observed that
although peak symmetry improved and run times were reduced
from 30 to 10 minutes as the temperature increased, the
resolution was dramatically affected and separation factors
decreased from 1.8 at 20 C to 1.5 at 40 C and 1.35 at 60 C. It
was thus decided that further experiments should be run at 20 C
(Fig. 4).
Once the optimum chromatographic conditions were estab-
lished, direct analysis of a commercial ibuprofen tablet was
attempted. The tablet was ground to a fine powder and 20 mg
were dissolved in 10 mL of CH3CN–H2O 40 : 60. This solution
was injected directly on the MIP LC column and while all
excipients eluted near the solvent front, we were able to resolve
the two enantiomers of ibuprofen found in the formulation and
achieve accurate determination of the drug concentration.
Finally, a staircase frontal chromatography experiment was
performed, using the optimised chromatographic conditions
described above. A wide range of S-ibuprofen concentrations
was tested from 106 mol L1 to 103 mol L1 and a total of 30
points were collected for each column (MIP and NIP). The
amounts of bound analyte during each step were then plotted
against the corresponding analyte concentration and two binding
isotherms were constructed (Fig. 5). The imprinted polymer
Table 1 Retention times (tR, min) of S-ibuprofen and structural analogues on imprinted and non-imprinted polymer packed HPLC columns, in
CH3CN and CH3CN–H2O (40 : 60)
Analyte
CH3CN CH3CN–H2O (40 : 60)
Imprinted Non-imprinted Imprinted Non-imprinted
S-Ibuprofen 6.5 2.2 17.0 2.5
R-Ibuprofen 4.5 2.2 10.2 2.5
S-Flurbiprofen 7.3 4.6 16.3 2.4
R-Flurbiprofen 7.3 4.6 12.0 2.4
S-Naproxen 7.5 3.6 9.2 2.0
S-Ketoprofen 3.9 5.6 5.8 1.7
R-Ketoprofen 3.9 5.6 5.8 1.7
S-2-PPA 4.5 3.6 3.5 1.4
R-2-PPA 4.5 3.6 3.5 1.4
S-Indoprofen 7.5 6.0 4.3 1.5
R-Indoprofen 7.5 6.0 4.3 1.5
Fig. 3 Imprinting factors (kMIP/kNIP) for ibuprofen and structurally
related compounds in CH3CN and CH3CN–H2O (40 : 60) (2-PPA : 2-
phenylpropanoic acid).
Fig. 4 Elution profiles of 0.1 mmol L1 rac-ibuprofen injected on the S-
ibuprofen imprinted column. From bottom to top: column temperature
20 C, 40 C and 60 C. Dashed line: 0.1 mmol L1 S-ibuprofen injected
on S-ibuprofen imprinted column at 20 C. Traces are shown in scale but
have been off-set on the y-axis for clarity. Insert: 1 mmol L1
rac-ibuprofen injection at 20 C. Mobile phase: CH3CN–H2O (40 : 60),
flow-rate: 0.5 mL min1.
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clearly exhibits significantly higher affinity for S-ibuprofen
throughout the range of concentrations tested, compared to the
non-imprinted polymer. The plotted curves were fitted to the
Freundlich isotherm q ¼ aCm, where q is the amount of adsorbed
analyte, a is a coefficient, C the concentration of the analyte in
the mobile phase and m the heterogeneity index. Parameters
a and m where calculated by non-linear regression of the exper-
imental data and using the equations detailed in the article by
Umpleby et al.,21 the average affinity constant K and the average
number of binding sites N were extracted. Interestingly, the
Freundlich model calculated that both MIP and NIP polymers
have the same average affinity constant of 1.47 0.02 104 M1.
However, the difference in the performance of the two polymers
regarding the retention of S-ibuprofen as established by chro-
matographic evaluation, can be attributed to the starkly different
average number of binding sites, with the MIP containing 2.19 
0.01 mmol g1 and the NIP 0.23 0.01 mmol g1. The similarity of
affinity constants could be ascribed to the fact that both poly-
mers contain the same ingredients, and more importantly the
same functional monomer, while the introduction of S-ibuprofen
at the pre-polymerisation mixture is responsible for the genera-
tion of specific recognition points, hence the nearly 10-fold
difference in average number of binding sites, clearly demon-
strated by the corresponding affinity distribution plot (Fig. 5,
insert). This difference is in remarkable agreement with the
calculated imprinting factor for S-ibuprofen discussed
previously.
3.4. Solid phase extractions
The synthesised polymers were subsequently tested in MI-SPE in
order to establish whether they could be used as selective
sorbents for the extraction of ibuprofen from complex samples.
Initially, extractions of aqueous standard solutions
(200 mg mL1) were attempted and the percentage of acetonitrile
as the organic modifier in the wash step was varied between 0 and
40%, while elution was performed with CH3CN containing 1%
acetic acid. It was found that ibuprofen recoveries decreased as
the percentage of CH3CN in the wash step increased and when
pure water or up to 20% CH3CN was used recoveries averaged
92%, decreased to 85% at 30% CH3CN and 63% at 40% CH3CN.
Interestingly, the selectivity of the MIP increased in the same
order, as the recoveries on the MIP and NIP were equal at 0 and
20% CH3CN, a ratio of 1.4 was reached at 40% (Fig. 6). This
result exemplifies the role of the organic modifier in the wash step
ofMI-SPE, commonly referred to as the ‘‘molecular recognition’’
step: in purely aqueous mobile phases non-specific hydrophobic
binding dominates while the addition of an organic solvent plays
an important role in making the selective binding sites accessible
to the template molecules.
Based on these results and the common assumption that
imprinted polymers perform best when applied in the solvent
which was used as a porogen during their synthesis, we decided to
use toluene as the organic solvent at the molecular recognition
step. Hence, after loading the sample, the polymer phase was
washed with 2 mL of toluene, followed by complete drying of the
bed and finally elution of the retained analyte. Indeed, this
protocol resulted in recoveries averaging 86.3% on the MIP
column and 29.1% on the NIP, a ratio of 3, verifying the above
hypothesis.
We then modified this protocol adding an aqueous wash after
loading the sample to remove any water soluble compounds from
the column, and applied it in the extraction of commercial
ibuprofen tablets, as well as spiked (200 mg mL1) blood serum
and urine samples. The results are summarised in Table 2.
Recoveries from ibuprofen tablets were comparable to the ones
obtained from aqueous standards although the differences
between MIP and NIP were smaller. Furthermore, significantly
reduced recoveries were initially achieved from urine and blood
Fig. 5 Binding isotherms of S-ibuprofen on MIP (A) and NIP (>)
columns and corresponding curves fitted to the Freundlich isotherm
model (dashed lines). Insert: affinity distribution plots.
Fig. 6 Ibuprofen recovery (%) dependence on CH3CN content in the
wash step (bars) and corresponding imprinting factors (dashed line).
Table 2 Ibuprofen recoveries (%) using an optimised SPE protocol.
Conditions: loading: 2 mL of aqueous sample; 1st wash: 2 mL H2O, 2
nd
wash: 2 mL toluene, elution: 1 mL CH3CN–1% CH3COOH. Blood and
urine samples spiked with 200 mg mL1 ibuprofen and pH was adjusted
to 4
Sample Imprinted Non-imprinted
H2O 86.3  2 29.1  2
Tablet 84.7  3 50.0  4
Blood serum 92.2  4 56.8  2
Urine 87.3  3 47.1  4
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serum samples averaging just 24.1% at physiological pH. This
was ascribed to the acidic character of ibuprofen that is found in
the carboxylate anion form at pH values near 7. In this form, the
donor–acceptor array is no longer present, hence the analyte is
not complementary to the functional monomer. Consequently,
when the pH was reduced to 4 by addition of a few drops of 1 M
aqueous HCl, recoveries of up to 92.2% were achieved, con-
firming the proposed two-point hydrogen bond complexation.
It should be noted here that throughout this series of SPE
experiments, totalling at least 100 extraction cycles, the same 25
mg MIP cartridge was used and no loss in performance or
reproducibility was evident, verifying the robustness and reus-
ability of imprinted materials compared to biological affinity
media.
4. Conclusions
A complete pre-polymerisation study of the 2-acrylamido-4-
methylpyridine–ibuprofen system was performed by 1H NMR
titration and dilution studies. The apparent association constant
for the 1 : 1 complex was found to be lower than the expected
value and this was attributed to significant dimerisation of
ibuprofen in the studied solution. Stoichiometrically imprinted
polymers for S-ibuprofen were synthesised using a 1 : 1 ratio of
the functional monomer and the drug. The materials exhibited
strong affinity and selectivity for the templated structure versus
other related NSAIDs, both in organic and aqueous media,
containing up to 60% water, and imprinting factors of 5 and 10
respectively were obtained. Complete resolution of ibuprofen
enantiomers was achieved in predominantly aqueous mobile
phases, using 30 mm columns, minute solvent consumption and
in relatively short run times. Chromatographic separations per-
formed at elevated temperatures resulted in much faster runs at
the expense of resolution, albeit elution profiles obtained at 40 C
could perhaps be further fine-tuned to achieve complete enan-
tiomer resolution in less than 15 minutes. MI-SPE experiments
using just 25 mg of packing material resulted in excellent
recoveries of the drug from aqueous standard solutions,
commercial tablets, urine and blood serum samples, while the
only sample pre-treatment necessary was a simple dilution and
adjustment of the pH to ensure the drug was present in the
desirable neutral carboxylic acid form.
The results presented here, when directly compared to
previous reports found in literature, clearly demonstrate that
imprinted materials with superior performance are readily
accessible using simple, custom-made building blocks, optimised
for each targeted analyte.
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